Advanced company searchLink opens in new window

INVENTA THERAPEUTICS LIMITED

Company number 11032260

Filter by category

Filter by category


Confirmation statement filters

Company Results (links open in a new window)
Date (document was filed at Companies House) Type Description (of the document filed at Companies House) View / Download (PDF file, link opens in new window)
29 Oct 2024 CS01 Confirmation statement made on 25 October 2024 with no updates
15 Aug 2024 AA Total exemption full accounts made up to 31 December 2023
23 Nov 2023 CS01 Confirmation statement made on 25 October 2023 with no updates
06 Jul 2023 AA Total exemption full accounts made up to 31 December 2022
27 Jan 2023 DISS40 Compulsory strike-off action has been discontinued
26 Jan 2023 AD01 Registered office address changed from Biocity Pennyfoot Street Nottingham Nottinghamshire NG1 1GF to 10 Colwick Quays Business Park Road No 2 Colwick Nottingham NG4 2JY on 26 January 2023
26 Jan 2023 CS01 Confirmation statement made on 25 October 2022 with no updates
17 Jan 2023 GAZ1 First Gazette notice for compulsory strike-off
30 Sep 2022 AA Total exemption full accounts made up to 31 December 2021
02 Feb 2022 DISS40 Compulsory strike-off action has been discontinued
01 Feb 2022 CS01 Confirmation statement made on 25 October 2021 with updates
11 Jan 2022 GAZ1 First Gazette notice for compulsory strike-off
08 Sep 2021 AA Total exemption full accounts made up to 31 December 2020
22 Feb 2021 AA01 Previous accounting period extended from 31 October 2020 to 31 December 2020
14 Dec 2020 SH01 Statement of capital following an allotment of shares on 11 December 2020
  • GBP 127.82
14 Dec 2020 CS01 Confirmation statement made on 25 October 2020 with updates
22 Oct 2020 MA Memorandum and Articles of Association
22 Oct 2020 RESOLUTIONS Resolutions
  • RES10 ‐ Resolution of allotment of securities
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES13 ‐ Section 175 14/09/2020
  • RES01 ‐ Resolution of adoption of Articles of Association
19 Oct 2020 SH01 Statement of capital following an allotment of shares on 14 September 2020
  • GBP 126.56
19 Aug 2020 AA Total exemption full accounts made up to 31 October 2019
29 Jun 2020 CH01 Director's details changed for Dr Shailendra Rambaran Singh on 26 June 2020
11 Nov 2019 SH01 Statement of capital following an allotment of shares on 21 October 2019
  • GBP 125.00
11 Nov 2019 SH02 Sub-division of shares on 21 October 2019
10 Nov 2019 RESOLUTIONS Resolutions
  • RES11 ‐ Resolution of removal of pre-emption rights
  • RES13 ‐ Sub-division 21/10/2019
08 Nov 2019 AP01 Appointment of Mr Ashley Stephen Charles Cooper as a director on 21 October 2019